STAGE I BREAST CANCER AJCC V7

This phase 3 trial tests whether adding the immunotherapy drug pembrolizumab after standard chemotherapy helps prevent triple-negative breast cancer from returning. About 1,155 patients with residual cancer after chemo are randomly assigned to receive pembrolizumab or a placebo. …

This study tests whether giving a higher dose of radiation to only the part of the breast where cancer started (instead of the whole breast) can reduce side effects and still control the cancer. About 928 women with early-stage breast cancer who had lumpectomy will receive this s…

This study looks at how well proton beam radiation works for women with early-stage breast cancer (stages 0 to II). The goal is to see if this type of radiation can kill cancer cells while causing fewer side effects and better cosmetic results compared to standard radiation. Abou…

This study compares a 3-week course of radiation to the standard 5-week course for breast cancer patients who also need radiation to nearby lymph nodes. The goal is to see if the shorter treatment reduces arm swelling (lymphedema) while keeping the risk of cancer returning low. A…

This study tests if a special type of acupuncture (electroacupuncture) can reduce chronic pain in women who have finished treatment for early-stage breast cancer. About 111 women with persistent pain for at least 3 months after surgery will receive either real acupuncture, a sham…